Behaviour change interventions to reduce second-hand smoke (SHS) exposure at home in pregnant women - A systematic review and intervention appraisal

Abstract Background Second-hand smoke (SHS) exposure during pregnancy is associated with poor pregnancy and foetal outcomes. Theory-based behaviour change interventions (BCI) have been used successfully to change smoking related behaviours and offer the potential to reduce exposure of SHS in pregnant women. Systematic reviews conducted so far do not evaluate the generalisability and scalability of interventions. The objectives of this review were to (1) report the BCIs for reduction in home exposure to SHS for pregnant women; and (2) critically appraise intervention-reporting, generalisability, feasibility and scalability of the BCIs employed. Methods Standard methods following PRISMA guidelines were employed. Eight databases were searched from 2000 to 2015 in English. The studies included used BCIs on pregnant women to reduce their home SHS exposure by targeting husbands/partners. The Workgroup for Intervention Development and Evaluation Research (WIDER) guidelines were used to assess intervention reporting. Generalisability, feasibility and scalability were assessed against criteria described by Bonell and Milat. Results Of 3479 papers identified, six studies met the inclusion criteria. These studies found that BCIs led to increased knowledge about SHS harms, reduction or husbands quitting smoking, and increased susceptibility and change in level of actions to reduce SHS at home. Two studies reported objective exposure measures, and one reported objective health outcomes. The studies partially followed WIDER guidelines for reporting, and none met all generalisability, feasibility and scalability criteria. Conclusions There is a dearth of literature in this area and the quality of studies reviewed was moderate to low. The BCIs appear effective in reducing SHS, however, weak study methodology (self-reported exposure, lack of objective outcome assessment, short follow-up, absence of control group) preclude firm conclusion. Some components of the WIDER checklist were followed for BCI reporting, scalability and feasibility of the studies were not described. More rigorous studies using biochemical and clinical measures for exposures and health outcomes in varied study settings are required. Studies should report interventions in detail using WIDER checklist and assess them for generalisability, feasibility and scalability. Trial registration CRD40125026666

Probing high temperature ferromagnetism and its paramagnetic phase change due to Eu3+ incorporation in ZnO nanophosphors

Ferromagnetic oxide semiconductors exhibiting efficient luminescent properties together with robust ferromagnetism above room temperature form an exclusive class of spintronic materials endowed with both charge and spin degrees of freedom. Herein, we report on the occurrence of high temperature ferromagnetism (>600 K) in zinc oxide nanophosphors attributed to the presence of defects in the host lattice and wherein incorporation of rare earth ions contributed to a gradual reduction in the ferromagnetic character and steady transformation to paramagnetic behavior. Although undoped ZnO nanophosphors exhibit a high coercive field and saturation magnetization along with a prominent green emission (536 nm) attributed to the presence of oxygen vacancies V-o, Eu3+ doping results in a decrease in green emission along with coercivity as well as magnetization efficient line emission in the orange red region (618-622 nm) pointing to a definite correlation between the V-o and ferromagnetism. The temperature dependence of the magnetization shows stable ferromagnetism with Curie temperature above 600 K for undoped ZnO and a ferromagnetic to paramagnetic transition with an increase in Eu3+ concentration that has been explained through an F+ center exchange mechanism